Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Swedish MTP Council recommended delaying the introduction of robotic surgery for knee, hip, and spine

27 Jun 2023

On June 13, 2023, the Swedish Medical Technologies Product (MTP) Council recommended that all regions delay the introduction of robotic systems for knee, hip, and spine surgery until they have been evaluated as part of the Orderly introduction framework. For now, MTP Council recommends robotic systems in these indications only to be used in the context of research.

The Orderly introduction framework supports the national adoption of novel technologies via a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation by the Swedish Dental and Pharmaceutical Benefits Agency (TLV), and recommendations by the MTP Council to regions regarding the implementation of the technology and criteria for use.

The MTP Council was informed about the region's interest in using robotic systems. As the costs are high, and the benefits are not yet clear, MTP Council decided to make a wait-and-see recommendation for now. The MTP Council will commission the TLV to perform a health economic assessment of these products. Based on the results, the MTP Council will make final recommendations to the regions.

See more information here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.